Diamond Therapeutics Revenue and Competitors

Toronto, ON CAN

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Diamond Therapeutics's estimated annual revenue is currently $904.5k per year.(i)
  • Diamond Therapeutics's estimated revenue per employee is $100,500

Employee Data

  • Diamond Therapeutics has 9 Employees.(i)
  • Diamond Therapeutics grew their employee count by -18% last year.

Diamond Therapeutics's People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
VP, Pharmaceutical DevelopmentReveal Email/Phone
4
Innovation and PartnershipsReveal Email/Phone
5
Founding Investor & AdvisorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$18.5M92-1%N/AN/A
#2
$14.3M716%N/AN/A
#3
$36M1798%N/AN/A
#4
$7.8M398%N/AN/A
#5
$17.9M933%$192.2MN/A
#6
$64.9M3234%N/AN/A
#7
$0.5M5-55%N/AN/A
#8
$6.8M34-41%N/AN/A
#9
$19.5M9723%N/AN/A
#10
$2.5M2519%N/AN/A
Add Company

What Is Diamond Therapeutics?

The promise of a new and better class of mental health therapies lies within the chemistry of psychedelic compounds.Our mission is to unlock it.We're developing safe, FDA, EMA and Health Canada approved therapies for neuropsychiatric conditions, starting with sub-perceptual psilocybin-based medicines that have the potential to deliver greater impact than current first-line treatments.Our first clinical program is focused on accessible psilocybin-based drugs that deliver rapid therapeutic outcomes without perceptual side effects. By eliminating the side effects, this intervention can be administered to a broad cohort of patients.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$904.5k

Revenue (est)

-18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.1M913%$53M
#2
$0.9M9-18%N/A
#3
$0.7M9N/AN/A
#4
$0.1M9-18%$1.3M
#5
$0.7M9N/AN/A